Gilead Sciences to Present at the Goldman Sachs 39th Annual Global Healthcare Conference on Wednesday, June 13
May 30 2018 - 4:01PM
Business Wire
Webcast Available Through Gilead Corporate
Website
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Robin
L. Washington, Gilead’s Executive Vice President and Chief
Financial Officer, and John McHutchison, Gilead’s Chief Scientific
Officer and Head of Research & Development, will participate in
a fireside chat at the Goldman Sachs 39th Annual Global Healthcare
Conference in Rancho Palos Verdes, CA on Wednesday, June 13 at 8:40
a.m. Pacific Time.
The audio portion of the fireside chat will be accessible live
through the company’s Investors page at www.gilead.com/investors.
Please connect to the company’s website at least 15 minutes prior
to the start of the presentation to ensure adequate time for any
software download that may be required to listen to the webcast.
The replay will be available for 14 days following the
presentation.
About Gilead Sciences,
Inc.
Gilead Sciences, Inc. is a research-based biopharmaceutical
company that discovers, develops and commercializes innovative
medicines in areas of unmet medical need. The company strives to
transform and simplify care for people with life-threatening
illnesses around the world. Gilead has operations in more than 35
countries worldwide, with headquarters in Foster City,
California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180530006043/en/
Gilead Sciences, Inc.Sung Lee, 650-524-7792Investor
Relations
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024